SCHEMBL127960

SCHEMBL127960

[NH]CCC1CCCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1679363 1.00 CYP1A2 (0.48)
SCHEMBL1678886 0.97
SCHEMBL1099040 0.90
SCHEMBL129349 0.83
SCHEMBL128980 0.82 CYP1A2 (0.56)
SCHEMBL8392547 0.82 CYP1A2 (0.56)
SCHEMBL9292937 0.80 SIGMAR1 (0.56)
SCHEMBL133413 0.80 SIGMAR1 (0.56)
SCHEMBL2573209 0.79 CYP1A2 (0.58)
SCHEMBL11407095 0.79 CYP1A2 (0.58)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1165494-B1 HSV PRIMASE INHIBITORS BOEHRINGER INGELHEIM CA LTD (CA) 2003-11-05 EP claimed
EP-1165494-A2 HSV PRIMASE INHIBITORS BOEHRINGER INGELHEIM (CANADA) LTD. (CA) 2002-01-02 EP claimed
US-6323202-B1 BENZAMIDE SUBSTITUTES WITH KETONE COMPOUNDS AS ENZYME INHIBITORS BOEHRINGER INGELHEIM (CANADA) LTD. (CA) 2001-11-27 US claimed
WO-2000058270-A2 HSV PRIMASE INHIBITORS BOEHRINGER INGELHEIM (CANADA) LTD. (CA) 2000-10-05 WO claimed
EP-0443560-A2 HIV protease inhibitors BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) 1991-08-28 EP claimed
EP-0443573-A2 HIV protease inhibitors containing derived amino acids BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) 1991-08-28 EP claimed
US-20240116762-A1 SURFACE-MODIFIED NANODIAMONDS AND METHOD FOR PRODUCING SURFACE-MODIFIED NANO CARBON PARTICLES DAICEL CORPORATION (JP) 2024-04-11 US disclosed
US-20220177314-A1 SURFACE-MODIFIED NANODIAMONDS AND METHOD FOR PRODUCING SURFACE-MODIFIED NANO CARBON PARTICLES DAICEL CORPORATION (JP) 2022-06-09 US disclosed
EP-3984952-A1 SURFACE-MODIFIED NANODIAMONDS AND METHOD FOR PRODUCING SURFACE-MODIFIED NANO CARBON PARTICLES Daicel Corporation (JP) 2022-04-20 EP disclosed
CN-113993812-A Surface-modified nanodiamond and method for producing surface-modified nanocarbon particles 株式会社大赛璐 2022-01-28 CN disclosed
WO-2020250769-A1 SURFACE-MODIFIED NANODIAMONDS AND METHOD FOR PRODUCING SURFACE-MODIFIED NANO CARBON PARTICLES 株式会社ダイセル 2020-12-17 WO disclosed
US-9556158-B2 Fungicidal 3-[(pyridin-2-ylmethoxyimino)(phenyl)methyl]-2-substituted-1,2,4-oxadiazol-5(2H)-one derivatives BAYER INTELLECTUAL PROPERTY GMBH (DE) 2017-01-31 US disclosed
EP-2755949-B1 FUNGICIDAL 4-SUBSTITUTED-3-{PHENYL[(HETEROCYCLYLMETHOXY)IMINO]METHYL}-1,2,4-OXADIZOL-5(4H)-ONE DERIVATIVES BAYER IP GMBH (DE) 2015-10-21 EP disclosed
EP-0443560-A2 HIV protease inhibitors BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) 1991-08-28 EP disclosed
EP-0433879-A2 Aminothiazoles BASF Aktiengesellschaft (DE) 1991-06-26 EP disclosed
EP-0421441-A2 Pantothenic acid derivatives FUJIREBIO INC. (JP) 1991-04-10 EP disclosed
EP-0392317-A2 Benzimidazoles, drugs containing these compounds and process for their preparation Dr. Karl Thomae GmbH (DE) 1990-10-17 EP disclosed
US-4954504-A Hypotensive agents, psychotic disorders CIBA-GEIGY CORPORATION (US) 1990-09-04 US disclosed
US-4709010-A TREATING OR PREVENTING HYPERTENSION OR HYPERALDESTERONISM MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1987-11-24 US disclosed
EP-0179352-A2 Peptides MERCK PATENT GmbH (DE) 1986-04-30 EP disclosed